We performed an epigenome-wide analysis of livers from Pcyt2 + /- NASH mice without and with PEA treatment to characterize how changes in DNA methylation may have influenced the reversal of Pcyt2 + /- NASH in PEA treated livers. This evidence concerns the gene PCYT2 and metabolic dysfunction-associated steatohepatitis.